Cranney A - Search Results

1

Corticosteroid-induced osteoporosis: a guide to optimum management.

Cranney A, Adachi JD. Cranney A, et al. Treat Endocrinol. 2002;1(5):271-9. doi: 10.2165/00024677-200201050-00001. Treat Endocrinol. 2002. PMID: 15832482 Review.

2

Rational use of oral bisphosphonates for the treatment of osteoporosis.

Mathoo JM, Cranney A, Papaioannou A, Adachi JD. Mathoo JM, et al. Among authors: cranney a. Curr Osteoporos Rep. 2004 Mar;2(1):17-23. doi: 10.1007/s11914-004-0010-6. Curr Osteoporos Rep. 2004. PMID: 16036078 Review.

3

Benefit-risk assessment of raloxifene in postmenopausal osteoporosis.

Cranney A, Adachi JD. Cranney A, et al. Drug Saf. 2005;28(8):721-30. doi: 10.2165/00002018-200528080-00006. Drug Saf. 2005. PMID: 16048357 Review.

4

Risedronate for the prevention and treatment of postmenopausal osteoporosis.

Cranney A, Waldegger L, Zytaruk N, Shea B, Weaver B, Papaioannou A, Robinson V, Wells G, Tugwell P, Adachi JD, Guyatt G. Cranney A, et al. Cochrane Database Syst Rev. 2003;(4):CD004523. doi: 10.1002/14651858.CD004523. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2007 Jul 18;(1):CD004523. doi: 10.1002/14651858.CD004523.pub2 PMID: 14584020 Updated. Review.

5

Intermittent cyclic therapy with etidronate prevents corticosteroid-induced bone loss: two years of follow-up.

Sebaldt RJ, Adachi JD, Bensen WG, Bianchi F, Cividano A, Craig GL, Cranney A, Kaminska E, Gordon M, Steele M, Goldsmith C. Sebaldt RJ, et al. Among authors: cranney a. Scand J Rheumatol Suppl. 1996;103:91-3. doi: 10.3109/03009749609103760. Scand J Rheumatol Suppl. 1996. PMID: 8966498 Clinical Trial.

6

A metaanalysis on the use of bisphosphonates in corticosteroid induced osteoporosis.

Homik JE, Cranney A, Shea B, Tugwell P, Wells G, Adachi JD, Suarez-Almazor ME. Homik JE, et al. Among authors: cranney a. J Rheumatol. 1999 May;26(5):1148-57. J Rheumatol. 1999. PMID: 10332982

7

Development and pilot testing of a decision aid for postmenopausal women with osteoporosis.

Cranney A, O'Connor AM, Jacobsen MJ, Tugwell P, Adachi JD, Ooi DS, Waldegger L, Goldstein R, Wells GA. Cranney A, et al. Patient Educ Couns. 2002 Jul;47(3):245-55. doi: 10.1016/s0738-3991(01)00218-x. Patient Educ Couns. 2002. PMID: 12088603

8

Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis.

Cranney A, Tugwell P, Zytaruk N, Robinson V, Weaver B, Shea B, Wells G, Adachi J, Waldegger L, Guyatt G; Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group. Cranney A, et al. Endocr Rev. 2002 Aug;23(4):540-51. doi: 10.1210/er.2001-6002. Endocr Rev. 2002. PMID: 12202469 Review.

9

Do hip protectors decrease the risk of hip fracture in institutional and community-dwelling elderly? A systematic review and meta-analysis of randomized controlled trials.

Sawka AM, Boulos P, Beattie K, Thabane L, Papaioannou A, Gafni A, Cranney A, Zytaruk N, Hanley DA, Adachi JD. Sawka AM, et al. Among authors: cranney a. Osteoporos Int. 2005 Dec;16(12):1461-74. doi: 10.1007/s00198-005-1932-2. Epub 2005 Jul 1. Osteoporos Int. 2005. PMID: 15990949 Review.

10

Parathyroid hormone for the treatment of osteoporosis: a systematic review.

Cranney A, Papaioannou A, Zytaruk N, Hanley D, Adachi J, Goltzman D, Murray T, Hodsman A; Clinical Guidelines Committee of Osteoporosis Canada. Cranney A, et al. CMAJ. 2006 Jul 4;175(1):52-9. doi: 10.1503/cmaj.050929. CMAJ. 2006. PMID: 16818910 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters